# JLA: Conversion To Creatinine, Creatine

- Device class: 1; regulation: 21 CFR 862.1210; FDA's rule: 510(k) exempt
- FDA decisions: 2
- Recalls: 1 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026; MAUDE to Sep 30, 2026

## Decisions per year (last 10)
- 1986: 2

## Most-cited predicates
- K854016: Asserachrom Protein C Kit (1986), cited by 1

Source page: https://510kreport.com/product-code/JLA
Data by year (CSV): https://510kreport.com/product-code/JLA.csv